A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD
Y Yilmaz, CD Byrne, G Musso - Expert review of gastroenterology & …, 2021 - Taylor & Francis
Introduction: We are currently at the dawn of a revolution in the field of fatty liver diseases.
Recently, a consensus recommended 'metabolic (dysfunction) associated fatty liver …
Recently, a consensus recommended 'metabolic (dysfunction) associated fatty liver …
Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019
Background & Aim Non-alcoholic fatty liver disease (NAFLD) has become a major cause of
chronic liver disease (CLD) worldwide. Our aim was to assess the burden of liver …
chronic liver disease (CLD) worldwide. Our aim was to assess the burden of liver …
From NAFLD to MAFLD: a" redefining" moment for fatty liver disease
The term non-alcoholic fatty liver disease (NAFLD) was coined in 1980 to characterize a
disease similar to alcoholic fatty liver disease that developed in patients without a history of …
disease similar to alcoholic fatty liver disease that developed in patients without a history of …
Role of intensive dietary and lifestyle interventions in the treatment of lean nonalcoholic fatty liver disease patients
Methods In total, 35 patients (14 lean and 21 obese) were included in the study. All patients
underwent transient elastography examinations, and controlled attenuation parameter …
underwent transient elastography examinations, and controlled attenuation parameter …
Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver …
Background/aim Simple noninvasive fibrosis scores based on routine blood tests have been
increasingly investigated as screening tools in different clinical settings. Here, we sought to …
increasingly investigated as screening tools in different clinical settings. Here, we sought to …
Among simple non-invasive scores, Pro-C3 and ADAPT best exclude advanced fibrosis in Asian patients with MAFLD
Background With metabolic dysfunction-associated fatty liver disease (MAFLD) incidence
and prevalence increasing, it is necessary to identify patients with advanced fibrosis (F3-F4 …
and prevalence increasing, it is necessary to identify patients with advanced fibrosis (F3-F4 …
[HTML][HTML] Fatty liver disease: Diagnosis and treatment
E Topal, K Aydemir, Ö Çağlar, B Arda… - Journal of Experimental …, 2021 - jebms.org
The liver is the largest organ of our body, which plays a role in the physiological process in
the body and is most exposed to toxins. The liver's functions are essential for life since it is …
the body and is most exposed to toxins. The liver's functions are essential for life since it is …
[HTML][HTML] The prevalence of metabolic-associated fatty liver disease in the Turkish population: A multicenter study
Materials and Methods: A total of 909 consecutive patients who presented with dyspepsia at
8 tertiary care centers in Turkey between March 2019 and December 2019 were included …
8 tertiary care centers in Turkey between March 2019 and December 2019 were included …
[HTML][HTML] Nonalcoholic fatty liver disease and portal hypertension
Nonalcoholic fatty liver disease (NAFLD) is a substantial and growing problem worldwide
and has become the second most common indication for liver transplantation as it may …
and has become the second most common indication for liver transplantation as it may …
[HTML][HTML] The utility of noninvasive scores in non-alcoholic fatty liver disease patients with normal and elevated serum transaminases
Results FIB-4 cutoffs of< 1.3 and< 1.45 for low risk of advanced fibrosis had a sensitivity of
70% and 54% in patients with elevated transaminases and 70% and 52% in patients with …
70% and 54% in patients with elevated transaminases and 70% and 52% in patients with …